Divestments

HyTest

HyTest is a recognized producer of high-quality antibodies and antigens for the diagnostic industry all around the world

Founded in 1994 as a spinoff from a project within Turku University, HyTest is today a high-quality, global antibody and antigen manufacturer and supplier, primarily targeting in vitro diagnostics OEMS and research organizations. The company is headquartered in Turku.

  • Sektor
    Healthcare
  • Land
    Finland
  • Fond
    EQT Mid-Market Credit,EQT Mid-Market Credit II
  • Entry
    2018
  • Exit
    2020-10-01

EQT Credit provided a Unitranche financing to support Summa Equity’s acquisition of HyTest, which is expected to benefit from the attractive market driven by non-cyclical, stable growth drivers.

To HyTest

Prenumerera

Prenumerera på EQT:s press releaser, regulatoriska press releaser och updates.

Typ av nyheter
Preferred language
EQT logo
© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180